Gulf International Bank UK Ltd held its stake in shares of Cigna Corp. (NYSE:CI) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 76,642 shares of the company’s stock at the end of the third quarter. Gulf International Bank UK Ltd’s holdings in Cigna Corp. were worth $9,987,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Acrospire Investment Management LLC increased its stake in shares of Cigna Corp. by 166.7% in the second quarter. Acrospire Investment Management LLC now owns 800 shares of the company’s stock valued at $102,000 after buying an additional 500 shares in the last quarter. Invictus RG increased its stake in shares of Cigna Corp. by 1,056.8% in the second quarter. Invictus RG now owns 1,018 shares of the company’s stock valued at $130,000 after buying an additional 930 shares in the last quarter. M&R Capital Management Inc. bought a new stake in shares of Cigna Corp. during the second quarter valued at $153,000. Johnson Financial Group Inc. increased its stake in shares of Cigna Corp. by 996.9% in the second quarter. Johnson Financial Group Inc. now owns 1,426 shares of the company’s stock valued at $183,000 after buying an additional 1,296 shares in the last quarter. Finally, Thompson Davis & CO. Inc. increased its stake in shares of Cigna Corp. by 2,981.6% in the second quarter. Thompson Davis & CO. Inc. now owns 1,510 shares of the company’s stock valued at $193,000 after buying an additional 1,461 shares in the last quarter. 84.62% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Cigna Corp. (NYSE:CI)

Cigna Corp. (NYSE:CI) traded down 1.37% during mid-day trading on Monday, reaching $136.77. The company had a trading volume of 1,189,865 shares. Cigna Corp. has a 12 month low of $115.03 and a 12 month high of $148.99. The firm has a market capitalization of $35.11 billion, a P/E ratio of 18.59 and a beta of 0.50. The stock’s 50-day moving average is $127.74 and its 200 day moving average is $129.22.

Cigna Corp. (NYSE:CI) last released its quarterly earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.03. Cigna Corp. had a return on equity of 16.17% and a net margin of 4.87%. The company earned $9.90 billion during the quarter, compared to analysts’ expectations of $4.37 billion. During the same quarter in the prior year, the business posted $2.28 earnings per share. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. On average, analysts predict that Cigna Corp. will post $7.98 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2016/11/28/gulf-international-bank-uk-ltd-has-9987000-position-in-cigna-corp-ci.html.

Several equities research analysts recently weighed in on the company. Zacks Investment Research raised Cigna Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, October 4th. Leerink Swann reissued a “buy” rating and issued a $155.00 target price on shares of Cigna Corp. in a report on Monday, September 26th. Citigroup Inc. reduced their target price on Cigna Corp. from $174.00 to $146.00 and set a “buy” rating for the company in a report on Wednesday, August 3rd. Jefferies Group reduced their target price on Cigna Corp. from $160.00 to $153.00 and set a “buy” rating for the company in a report on Monday, August 1st. Finally, Goldman Sachs Group Inc. reissued a “buy” rating and issued a $160.00 target price on shares of Cigna Corp. in a report on Thursday, September 8th. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Cigna Corp. presently has a consensus rating of “Buy” and an average price target of $156.00.

In other news, insider Jason D. Sadler sold 4,000 shares of the stock in a transaction on Monday, October 31st. The stock was sold at an average price of $121.80, for a total value of $487,200.00. Following the completion of the transaction, the insider now owns 34,019 shares of the company’s stock, valued at $4,143,514.20. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP John M. Murabito sold 58,822 shares of the stock in a transaction on Monday, November 7th. The stock was sold at an average price of $125.09, for a total value of $7,358,043.98. Following the completion of the transaction, the executive vice president now directly owns 115,109 shares of the company’s stock, valued at approximately $14,398,984.81. The disclosure for this sale can be found here. 1.20% of the stock is owned by insiders.

About Cigna Corp.

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

5 Day Chart for NYSE:CI

Receive News & Stock Ratings for Cigna Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corp. and related stocks with our FREE daily email newsletter.